205 related articles for article (PubMed ID: 32240363)
1. Lymph-node Epstein-Barr virus concentration in diagnosing cervical lymph-node metastasis in nasopharyngeal carcinoma.
Li H; Huang C; Chen Q; Peng C; Zhang R; Shen J; Chen M; Mai H; Zou R
Eur Arch Otorhinolaryngol; 2020 Sep; 277(9):2513-2520. PubMed ID: 32240363
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.
Liu SL; Sun XS; Li XY; Tang LQ; Chen QY; Lin HX; Liang YJ; Yan JJ; Lin C; Guo SS; Liu LT; Li Y; Xie HJ; Tang QN; Liang H; Guo L; Mai HQ
Cancer Commun (Lond); 2019 Mar; 39(1):14. PubMed ID: 30925939
[TBL] [Abstract][Full Text] [Related]
3. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
[TBL] [Abstract][Full Text] [Related]
4. Patterns of EBV-positive cervical lymph node involvement in head and neck cancer and implications for the management of nasopharyngeal carcinoma T0 classification.
Luo WJ; Feng YF; Guo R; Tang LL; Chen L; Zhou GQ; Li WF; Liu X; Sun Y; Lin AH; Ma J; Mao YP
Oral Oncol; 2019 Apr; 91():7-12. PubMed ID: 30926066
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of immunohistochemical analysis and Epstein-Barr virus-encoded small RNAs in situ hybridisation of cell block sections obtained using fine-needle aspiration in nasopharyngeal carcinoma with lymph node metastasis.
Zhang Y; Yu X; Yang Y; Wang Y; Chen S; Zhou X
Diagn Cytopathol; 2019 Mar; 47(3):200-205. PubMed ID: 30593738
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of metastatic cervical lymph node stiffness in nasopharyngeal carcinoma: A prospective cohort study.
Sun XS; Wang JW; Han F; Zou RH; Yang ZC; Guo SS; Liu LT; Chen QY; Tang LQ; Mai HQ
Radiother Oncol; 2023 Dec; 189():109939. PubMed ID: 37806561
[TBL] [Abstract][Full Text] [Related]
7. Role of Epstein-Barr virus in fine-needle aspirates of metastatic neck nodes in the diagnosis of nasopharyngeal carcinoma.
Macdonald MR; Freeman JL; Hui MF; Cheung RK; Warde P; McIvor NP; Irish J; Dosch HM
Head Neck; 1995; 17(6):487-93. PubMed ID: 8847207
[TBL] [Abstract][Full Text] [Related]
8. [Effect of exosomes derived from human Epstein-Barr virus-positive nasopharyngeal carcinoma cells on lymphangiogenesis and lymph node metastasis].
Chen X; Li D; Huang Z; Zhong S; Cai L
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Dec; 40(12):1776-1783. PubMed ID: 33380393
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus DNA detection in the diagnosis of nasopharyngeal carcinoma.
Yap YY; Hassan S; Chan M; Choo PK; Ravichandran M
Otolaryngol Head Neck Surg; 2007 Jun; 136(6):986-91. PubMed ID: 17547993
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4) serological and molecular markers in cases of undetected primary tumor location.].
Senyuta NB; Smirnova KV; Kondratova VN; Ignatova AV; Mudunov AM; Dushenkina TE; Liechtenstein AV; Gurtsevich VE
Vopr Virusol; 2019; 64(5):229-237. PubMed ID: 32167688
[TBL] [Abstract][Full Text] [Related]
11. Utilization of the lymph node-to-primary tumor ratio of PET standardized uptake value and circulating Epstein-Barr virus DNA to predict distant metastasis in nasopharyngeal carcinoma.
Shen EY; Hung TM; Tsan DL; Cheng NM; Kang CJ; Huang SF; Hsu CL; Lin CY; Wang HM; Hsieh JC; Cheng AJ; Fan KH; Chang JT
Radiother Oncol; 2022 Dec; 177():1-8. PubMed ID: 35568282
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of Epstein-Barr virus BamH I "f" variant in nodal metastasis of nasopharyngeal carcinoma].
Liu QY; Han AJ; Yang QX; Dong Y; Wu JH; You SY; Li MF
Zhonghua Bing Li Xue Za Zhi; 2008 Mar; 37(3):160-4. PubMed ID: 18788591
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic role of FNA cytology in the evaluation of cervical lymph nodes in thyroid cancers: Combined evaluation of thyroglobulin in eluate from FNA cytology.
Tralongo P; Bruno C; Policardo F; Vegni F; Feraco A; Carlino A; Ferraro G; Milardi D; Navarra E; Pontecorvi A; Lombardi CP; Raffaelli M; Larocca LM; Pantanowitz L; Rossi ED
Cancer Cytopathol; 2023 Nov; 131(11):693-700. PubMed ID: 37519189
[TBL] [Abstract][Full Text] [Related]
14. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
[TBL] [Abstract][Full Text] [Related]
15. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].
Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X
Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma.
Liu W; Li H; Sheng H; Liu X; Chi P; Wang X; Mao M
Adv Ther; 2020 Oct; 37(10):4280-4290. PubMed ID: 32780356
[TBL] [Abstract][Full Text] [Related]
17. Integrating Postradiotherapy MRI-Detected Lymph Node Necrosis and Pre- and Posttreatment Epstein-Barr Virus-DNA for Risk Stratification in Nasopharyngeal Carcinoma.
Cao D; Li S; Li H; Liu L; Wang X; Quan T
J Magn Reson Imaging; 2023 Jul; 58(1):108-119. PubMed ID: 36326089
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
[TBL] [Abstract][Full Text] [Related]
19. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma.
Liang SB; Zhang N; Chen DM; Yang XL; Chen BH; Zhao H; Lu RL; Chen Y; Fu LW
Radiother Oncol; 2019 Mar; 132():223-229. PubMed ID: 30366725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]